Pharmaceuticals
Jim Cramer: Diversification Is Good for Offense, Not Just Defense
This health care selloff shows the value of diversification to protect our portfolios -- and to go on the offensive and find bargains.
Chart of the Day: UNH's Universal Healthcare Comments Sting Sector
The free press that the progressive push for Medicare got on Tuesday morning is hurting the healthcare sector.
Political Environment Pressures UnitedHealth Shares
UNH's operational strength can't overcome the potential political overhang at the moment.
UnitedHealth Group Receives Booster Shot From Healthy Earnings, Outlook
The health benefit giant's fundamentals are good, but there are more symptoms to consider for a proper examination.
Stalking an Entry in Regeneron Pharmaceuticals
A low-risk countertrend options trade may be worth a look in this name.
You Don't Have to Swing for the Fences With Every Investment in Small Caps
The way I do that is by using buy-write option strategies.
Johnson & Johnson or Pfizer: Which Big Pharma Dividend Stock Is a Better Buy?
Healthcare giants Johnson & Johnson and Pfizer offer a tough choice for dividend investors seeking the best returns.
Tesla's Debacle and 3 More Stocks to Carefully Watch
Look at the entirety of your portfolio and make sure there are no earnings blow-ups coming from the companies that you own.
Shift to CBD From Cigarettes Isn't Enough to Sustain Walgreens Stock
In fact, the de-emphasizing of cigarettes was blamed for declining same store sales.
Walgreens Market Outlook, ePharmacy Acceleration Pummel Pharmacy Stocks
The contagion in pharmacy stocks is spreading and secular trends aren't helping to find a solution anytime soon.